Frequently asked questions

We know that it seems like COVID-19 came out of nowhere, and suddenly there are medical options you may not be familiar with. While your healthcare provider is the best resource, you can find answers to commonly asked questions about VEKLURY below to help guide you and your loved ones during this challenging time.

Please note that this information is not a substitute for talking with a healthcare professional, who is the best source for learning about treatment options for COVID-19.

Q: What is VEKLURY® (remdesivir)?

VEKLURY is a prescription medicine used to treat COVID-19 in adults and children at least 12 years old and weighing at least 88 pounds requiring hospitalization.

Talk to a healthcare provider to see if VEKLURY may be an option for you.

Q: How does VEKLURY work?

The coronavirus that causes COVID-19 spreads in your body by making copies of itself. VEKLURY interrupts the way the coronavirus copies itself.

Q: What were the study results with VEKLURY?

View safety and study results here.

Q: What are the most common side effects of VEKLURY?

The most common side effect in clinical trials was nausea.

View other possible side effects here.

Q: How is VEKLURY given?

VEKLURY is given to you through a vein by intravenous (IV) infusion 1 time each day in the hospital for up to 10 days. Your healthcare provider will decide how many doses you need.

Q: Can VEKLURY be used in children?

VEKLURY is FDA approved for children 12 years of age and older and weighing at least 88 pounds (40 kg) requiring hospitalization.

It is not known if VEKLURY is safe and effective for the treatment of COVID-19 in hospitalized children who are less than 12 years of age or weigh less than 88 pounds (40 kg).

Please refer to this helpful guide for further information: Fact Sheet for Parents and Caregivers.

Q: How is VEKLURY different than the vaccine?

VEKLURY is an antiviral drug used to treat COVID-19 in patients who are hospitalized. A vaccine is a type of medication before coronavirus infection to prevent illness.

Q: How is VEKLURY different from other treatments?

VEKLURY is an FDA-approved antiviral medicine for COVID-19. An antiviral is a type of medicine that fights viruses inside your body—interrupting the way the viruses copy themselves.

Q: Is VEKLURY still being studied?

VEKLURY was FDA approved for the treatment of adults and pediatric patients at least 12 years of age and weighing at least 88 pounds (40 kg) based on 3 studies that have been completed. There are additional completed clinical trials and several ongoing studies of VEKLURY in the treatment of COVID-19.

Q: Where can I go for information if I still have questions?

It is understandable to have questions. The resources below are available to provide information and support, and always contact your healthcare provider to help answer your questions.

Important Safety Information

Collapse

Who should not take VEKLURY?

Do not take VEKLURY if you:

  • Are allergic to remdesivir or any of the other ingredients in VEKLURY.

What are the possible side effects of VEKLURY?

Serious side effects of VEKLURY may include:

  • Allergic reactions. VEKLURY can cause allergic reactions during or after infusion. Tell your healthcare provider right away if you get any of the following symptoms: changes to heart rate, rash, fever, nausea, sweating, shortness of breath, wheezing, or swelling of the lips, face, or throat.
  • Increase in liver enzymes. Increases in the amount of liver enzymes are common in people who have received VEKLURY and may be a sign of liver injury. Your healthcare provider will do blood tests to check your liver enzymes before and during treatment and may stop your treatment with VEKLURY if you develop new or worsening liver problems.

The most common side effect in people receiving VEKLURY is nausea. Tell your healthcare provider if you have any side effects that bother you or do not go away.

What should I tell my healthcare provider before receiving VEKLURY?

  • All your health problems. Be sure to tell your healthcare provider if you have or have had any allergies, kidney or liver problems, or any serious illnesses.
  • If you are pregnant or breastfeeding: It is not known if VEKLURY can harm your unborn baby or be passed to the baby in breast milk. If you are pregnant or breastfeeding, discuss your options and specific situation with your healthcare provider.
  • All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect how VEKLURY works. Especially tell your healthcare provider if you are taking any medicines that contain chloroquine phosphate or hydroxychloroquine sulfate.

How is VEKLURY given?

  • VEKLURY is given through a vein by intravenous (IV) infusion, one time each day for up to 10 days, as determined by your healthcare provider.

WHAT IS VEKLURY?

View All

Collapse

VEKLURY is a prescription medicine used to treat COVID-19 in adults and children at least 12 years old and weighing at least 88 pounds requiring hospitalization.

Talk to a healthcare provider to see if VEKLURY may be an option for you.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch, or call 1-800-FDA-1088.

Please see Important Facts about VEKLURY.



View All

WHAT IS VEKLURY?

View All

Collapse

VEKLURY is a prescription medicine used to treat COVID-19 in adults and children at least 12 years old and weighing at least 88 pounds requiring hospitalization.

Talk to a healthcare provider to see if VEKLURY may be an option for you.

Important Safety Information

Collapse

Who should not take VEKLURY?

Do not take VEKLURY if you:

  • Are allergic to remdesivir or any of the other ingredients in VEKLURY.

What are the possible side effects of VEKLURY?

Serious side effects of VEKLURY may include:

  • Allergic reactions. VEKLURY can cause allergic reactions during or after infusion. Tell your healthcare provider right away if you get any of the following symptoms: changes to heart rate, rash, fever, nausea, sweating, shortness of breath, wheezing, or swelling of the lips, face, or throat.
  • Increase in liver enzymes. Increases in the amount of liver enzymes are common in people who have received VEKLURY and may be a sign of liver injury. Your healthcare provider will do blood tests to check your liver enzymes before and during treatment and may stop your treatment with VEKLURY if you develop new or worsening liver problems.

The most common side effect in people receiving VEKLURY is nausea. Tell your healthcare provider if you have any side effects that bother you or do not go away.

What should I tell my healthcare provider before receiving VEKLURY?

  • All your health problems. Be sure to tell your healthcare provider if you have or have had any allergies, kidney or liver problems, or any serious illnesses.
  • If you are pregnant or breastfeeding: It is not known if VEKLURY can harm your unborn baby or be passed to the baby in breast milk. If you are pregnant or breastfeeding, discuss your options and specific situation with your healthcare provider.
  • All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect how VEKLURY works. Especially tell your healthcare provider if you are taking any medicines that contain chloroquine phosphate or hydroxychloroquine sulfate.

How is VEKLURY given?

  • VEKLURY is given through a vein by intravenous (IV) infusion, one time each day for up to 10 days, as determined by your healthcare provider.

WHAT IS VEKLURY?

View All

Collapse

VEKLURY is a prescription medicine used to treat COVID-19 in adults and children at least 12 years old and weighing at least 88 pounds requiring hospitalization.

Talk to a healthcare provider to see if VEKLURY may be an option for you.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch, or call 1-800-FDA-1088.

Please see Important Facts about VEKLURY.

Tap for Important Safety Information about VEKLURY

You are leaving the
VEKLURY® (remdesivir) website

GO BACK LEAVE SITE